MO:NYSEAltria Group, Inc. Analysis
Data as of 2026-06-11 - not real-time
$71.41
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Altria’s stock is trading just above its short‑term moving average, with the 20‑day SMA providing a modest floor while the 50‑day SMA remains below current levels, indicating a short‑term uptrend within a broader bullish environment. The RSI sits near the midpoint of its range, suggesting neutral momentum, yet the MACD histogram has turned negative, hinting at emerging bearish pressure. Price is probing a near‑term support zone and faces resistance close to recent highs, and the overall trend is classified as bullish despite the bearish MACD signal.
Fundamentally, the company delivers exceptionally high gross and operating margins, strong operating cash flow and free cash flow, and a dividend yield that ranks among the highest in the market. Revenue is growing modestly year over year, and earnings per share are expanding, supporting a forward PE that is comfortably below the current PE. The DCF‑derived fair value is essentially in line with the market price, leaving only a marginal downside, while analyst consensus leans toward a hold rating. The defensive consumer‑staples nature of the tobacco sector provides resilience, but regulatory scrutiny remains a notable headwind.
Given the mix of solid cash generation, attractive dividend, and a valuation that appears fair, the short‑term outlook calls for caution as technical indicators suggest a potential pullback. Over the medium horizon, the dividend’s sustainability and the company’s cash strength make a case for buying on dips. For long‑term investors seeking income and defensive exposure, the stock remains an appealing hold with upside potential if regulatory pressures ease.
Fundamentally, the company delivers exceptionally high gross and operating margins, strong operating cash flow and free cash flow, and a dividend yield that ranks among the highest in the market. Revenue is growing modestly year over year, and earnings per share are expanding, supporting a forward PE that is comfortably below the current PE. The DCF‑derived fair value is essentially in line with the market price, leaving only a marginal downside, while analyst consensus leans toward a hold rating. The defensive consumer‑staples nature of the tobacco sector provides resilience, but regulatory scrutiny remains a notable headwind.
Given the mix of solid cash generation, attractive dividend, and a valuation that appears fair, the short‑term outlook calls for caution as technical indicators suggest a potential pullback. Over the medium horizon, the dividend’s sustainability and the company’s cash strength make a case for buying on dips. For long‑term investors seeking income and defensive exposure, the stock remains an appealing hold with upside potential if regulatory pressures ease.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price testing near‑term support
- bearish MACD histogram
- high dividend yield offering cushion
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- strong cash flow and free cash flow generation
- fair valuation relative to DCF
- sustainable dividend supporting total return
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- defensive consumer‑staples positioning
- consistent dividend growth and yield
- robust operating margins and cash generation
Key Metrics & Analysis
Financial Health
Revenue Growth5.30%
Profit Margin39.52%
P/E Ratio14.9
ROA27.61%
P/B Ratio-37.2
Op. Cash Flow$8.9B
Free Cash Flow$8.5B
Technical Analysis
TrendBullish
RSI51.8
Support$68.23
Resistance$74.41
MA 20$71.93
MA 50$69.43
MA 200$64.53
MACDBearish
VolumeStable
Fear & Greed Index86.71
Valuation
Fair Value$71.16
Target Price$70.36
Upside/Downside-1.47%
GradeFair
TypeValue
Dividend Yield5.80%
Risk Assessment
Beta-0.35
Volatility32.11%
Sector RiskLow
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.